Zobrazeno 1 - 10
of 47
pro vyhledávání: '"F Purello-D'Ambrosio"'
Autor:
F Purello-D'Ambrosio, Luisa Ricciardi, Sebastiano Gangemi, S. Parmiani, Rosaria Alba Merendino, S. Isola, Paola Puccinelli
Publikováno v:
Clinical & Experimental Allergy. 31:1295-1302
Background Specific immunotherapy is the only currently available allergen-orientated treatment able to modify the natural history of respiratory allergic diseases. Safety and clinical efficacy of this treatment are well documented, but evidence abou
Autor:
A. Bene, Antonella Ruello, G. Lonbardo, E. Losi, F Purello-D'Ambrosio, Sebastiano Gangemi, Rosaria Alba Merendino
Publikováno v:
Scopus-Elsevier
Interleukin-18 (IL-18), a cytokine that plays an important role in the T-cell-helper type 1 response, acts as an angiogenesis and tumor suppressor. Intercellular adhesion molecule-1 (ICAM-1) has a potential role in immunoregulation by mediating immun
Autor:
Barresi L, Gianfilippo Bagnato, Luisa Ricciardi, Sebastiano Gangemi, S. Isola, F Purello-D'Ambrosio
Publikováno v:
Clinical & Experimental Allergy. 29:1143-1147
Background Nonallergic rhinitis with eosinophilia (NARES), accounting for some 15% of perennial rhinitis, is a nasal disorder whose main features are eosinophil counts in nasal smear higher than 10% and negative IgE tests. The mainstay of treatment i
Autor:
Adriana Arena, Rosaria Alba Merendino, Antonella Pirazzoli, F Purello-D'Ambrosio, Sebastiano Gangemi, Patrizia Di Blasi, Paola Lucia Minciullo, Antonella Ruello
Background: Interleukin-8 (IL-8), a potent chemotactic and activating factor for neutrophils and eosinophils, may be a crucial factor in severe asthma. The aim of this study was to evaluate the effect of fluticasone propionate (FP), a corticosteroid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3d184f3ea3f814f455bbd6d4baee3c
http://hdl.handle.net/11570/1891358
http://hdl.handle.net/11570/1891358
Publikováno v:
Scopus-Elsevier
Summary We present the case of bronchospastic reaction to clarithromycin had during a drug challenge test Personal allergic history was negative for respiratory allergies and positive for adverse drug reactions to general and regional anesthesia and
Publikováno v:
Journal of investigational allergologyclinical immunology. 10(5)
Previous studies have demonstrated improvements in health-related quality of life in asthmatic patients after treatment with fluticasone propionate. CD30 is a marker of Th2 lymphocytes, which are key cells in the pathogenesis of allergic inflammation
Autor:
F, Purello-D'Ambrosio, S, Gangemi, P L, Minciullo, G, Lombardo, L, Ricciardi, S, Isola, R A, Merendino
Publikováno v:
Allergologia et immunopathologia. 28(2)
Case of a 57-year-old hospital attendant with hand eczema. Patch tests were read at 2 and 3 days using the 1+ to 3+ scoring system recommended by the Contact Dermatitis Research Group.
Autor:
G. La Rosa, Rosaria Alba Merendino, F Purello-D'Ambrosio, Francesco Tomasello, Sebastiano Gangemi
Publikováno v:
Allergy. 55(4)
Publikováno v:
Journal of investigational allergologyclinical immunology. 9(4)
Fluticasone propionate is a very effective topical treatment for asthma. Interleukin-12, which is produced by monocyte-macrophage and B lymphocytic cell lines, plays an important role in the induction of Th1 cells; whereas interferon-gamma (IFN-gamma
Autor:
E Savi, Paola Puccinelli, S. Isola, N La Motta, F Purello-D'Ambrosio, Luisa Ricciardi, Sebastiano Gangemi, S. Parmiani
Publikováno v:
Allergy. 54(9)
Background: New routes of administering immunotherapy in respiratory allergy are being studied as an alternative to conventional injective immunotherapy. We carried out a study to evaluate the clinical efficacy and effects of sublingual immunotherapy